சுவர் வாழ்க்கை அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சுவர் வாழ்க்கை அறிவியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சுவர் வாழ்க்கை அறிவியல் Today - Breaking & Trending Today

New and improved assays driving discovery & health research


Special Feature: Harnessing the power of cell-based assays: New tools and techniques in 2021
From tackling COVID-19 variants to therapeutic discovery, novel organoids and more, advance your assay research with these exclusive interviews and free resources
03 Aug 2021
Cell-based assays form the core of life sciences research, helping to drive understanding of various cellular phenomena in health and disease. In this new special feature, read exclusive interviews with leading scientists and download free resources to accelerate your cell-based methods. Find out how to streamline your drug screening with high-throughput cell and compound dispensing, learn how to achieve walkaway cell viability analysis while maintaining cell health for longer, explore the development of novel treatments to tackle liver disease, and much more. ....

Veronica Gil , Erik Tillman , Tania Nolan , Chelcie Eller , How To Buy Cell Counting Technology , Beckman Coulter , Corning Life Sciences , Special Feature , Thermo Fisher , Svar Life Science , Thermo Fisher Scientific , Scientist Channel , Buy Cell Counting , ஏறிக் வரை , டானியா நோலன் , எப்படி க்கு வாங்க செல் எண்ணும் தொழில்நுட்பம் , பெக்மேன் கூல்டர் , கார்னிங் வாழ்க்கை அறிவியல் , சிறப்பு அம்சம் , தெர்மோ மீனவர் , சுவர் வாழ்க்கை அறிவியல் , தெர்மோ மீனவர் அறிவியல் , விஞ்ஞானி சேனல் , வாங்க செல் எண்ணும் ,

Researchers develop new therapy for metabolic liver disease


Editorial Article: Researchers develop a promising new therapy to tackle metabolic liver disease, NASH
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
03 Aug 2021
Dr. Erik Tillman, Principal Scientist at Akero Therapeutics
Non-alcohol related fatty liver disease (NAFLD) presents a global health crisis estimated to affect billions of people worldwide, including an estimated 100 million in the US alone
1. In this exclusive interview, we speak with Dr. Erik Tillman, Principal Scientist at Akero Therapeutics, to find out more about Akero’s pioneering work developing treatments for non-alcoholic steatohepatitis (NASH), a severe form of NAFLD that increases the risk for cardiovascular and liver-related morbidity and mortality. Tillman explains how he and his teammates are developing a multi-modal drug that may help treat the drivers of NASH and reverse liver scarring.  Tillman ....

Erik Tillman , Editorial Article , Principal Scientist , Akero Therapeutics , Svar Life Science , Svar Life , Life Science , Nature Medicine , ஏறிக் வரை , தலையங்கம் கட்டுரை , ப்ரிந்ஸிபல் விஞ்ஞானி , சுவர் வாழ்க்கை அறிவியல் , சுவர் வாழ்க்கை , வாழ்க்கை அறிவியல் , இயற்கை மருந்து ,